Notice: Phase III of Pre-Market Transparency Initiatives for Prescription Drugs

Description

As a regulator, Health Canada plays an important role in protecting the health and safety of Canadians. Health Canada is committed to being transparent and open about its activities and to making timely and useful information available about health products and health product submissions. Greater transparency and openness with Canadians strengthens the trust in our regulatory decisions, and ultimately supports Canadians in making better decisions about their health.

Resources

Name Format Description Link
Notice: Phase III of Pre-Market Transparency Initiatives for Prescription Drugs HTML https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/premarket-transparency-initiatives-notice.html
Notice: Phase III of Pre-Market Transparency Initiatives for Prescription Drugs HTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/annonces/initiatives-transparence-avant-marche-avis.html

Tags

Topics

Categories